Earnings Feed
Start Free
Anika Therapeutics, Inc.·4

Mar 17, 7:39 PM ET

McLeod Ian 4

Research Summary

AI-generated summary

Updated

Anika (ANIK) SVP Ian McLeod Receives Award, Exercises Derivatives

What Happened Ian McLeod, SVP, CAO & Treasurer of Anika Therapeutics (ANIK), received shares from vested RSUs/PSUs and conversions of derivative awards on March 14–15, 2026. In total he acquired 7,593 shares (3,774 + 1,161 + 2,658). To satisfy withholding obligations, the issuer retained 2,230 shares (1,449 on Mar 14 and 781 on Mar 15) — recorded as dispositions for tax withholding with an aggregate withholding value of $31,666 ($20,576 + $11,090). The underlying vesting/exercise entries are coded as awards (A) and derivative exercises/conversions (M); the withheld shares are coded F (tax withholding).

Key Details

  • Transaction dates: March 14–15, 2026. Filing date: March 17, 2026.
  • Shares acquired: 7,593 total (3,774; 1,161; 2,658).
  • Shares withheld for taxes: 2,230 total (1,449 @ $14.20 = $20,576; 781 @ $14.20 = $11,090). Total withholding ≈ $31,666.
  • Prices: The RSU/PSU/derivative conversions are reported with $0 exercise price (typical for vesting awards); withholding calculated at $14.20/share.
  • Shares owned after the transactions: not specified in the provided excerpt of the filing.
  • Footnotes of note:
    • F2/F5/F6: These transactions reflect vesting installments from prior PSU/RSU grants (including performance-based PSUs granted Mar 14, 2025 and multi-year RSU grants).
    • F3/F4: The 1,449 and 781 shares were retained by the issuer to satisfy tax withholding.
  • Filing timeliness: Form filed Mar 17, 2026 reporting transactions on Mar 14–15; the filing does not indicate a late-report flag in the provided excerpt.

Context

  • These transactions are primarily vesting/conversion events (awards and derivative conversions) rather than open-market purchases or discretionary sales. The retained shares are a routine tax-withholding action (often called a "sell-to-cover" or share retention) and do not necessarily indicate a market-directed sale by the insider.
  • The PSU entry noted is performance-based and vests only upon achievement of pre-set targets; the filing indicates this was the first vesting installment for that award.